ImmuDyne, Inc. Announces Annual Filing Update
April 17 2017 - 4:30PM
ImmuDyne, Inc. (OTCQB:IMMD) (“ImmuDyne” or the “Company”), a leader
in the development and marketing of OTC healthcare products, has
been informed by OTC Markets Group the company will
have until May 15, 2017 to file its Annual Report on Form
10K (prior to OTC Markets taking any action with respect to the
company).
ImmuDyne currently expects to finalize its financial
results and file its Annual Report on Form 10-K with
the SEC as soon as practicable and further expects that
the financial information contained in the Form 10-K will be
consistent in all material respects with the financial results
reported in our press release dated March 6, 2017.
Based on the review and analysis conducted to date, no
material adjustments, restatement or other revisions to previously
issued financial statements of the Company are currently expected
to be required.
About lmmuDyne lmmuDyne, Inc. (the "Company") is a health and
wellness company which develops, manufactures, markets, and sells
innovative lifestyle products. The Company's lead products contain
its proprietary yeast beta glucans that have been shown through
testing and analysis to support the immune system. The Company's
products include once a day oral intake capsules as well as topical
serums and creams for skin application. lmmuDyne also has developed
a proprietary natural delivery technology for potential new market
opportunities. All of lmmuDyne's intellectual property is protected
by patents and/or trade secrets. Additional information can be
found on the web at www.immudyne.com.
Forward-Looking Statements Cautionary language regarding
Forward-Looking Statements Safe Harbor Act Disclaimer: Forward
looking statements in this release are made pursuant to the Safe
Harbor Provisions of the Private Securities Litigation Reform Act
of 1995. Certain statements in this press release, including
projections with respect to lmmuDyne's results of operations, may
contain words such as "anticipates," "believes," "could,"
"estimates," "expects," "intends," "may," "projects,"
"plans," "targets" and other similar language and are
considered forward-looking statements. These statements are based
on management's current expectations, estimates, and forecasts.
These forward-looking statements are subject to important
assumptions, risks and uncertainties, which are difficult to
predict and therefore the actual results may be materially
different from those discussed.
Contact:
ImmuDyne, Inc.
Mark McLaughlin: +1-914-714-8901